A new study has found that people with multiple sclerosis, a devastating neurological condition, may not be at risk of developing breast and colorectal cancers. However, they could be at risk of developing bladder cancer. The Canadian study was published online in the journal Neurology.
The U.S. Food and Drug Administration (FDA) approved the use of PD-L1 IHC 22C3 pharmDx, a lab test developed by Agilent Technologies, to identify patients with triple-negative breast cancer who may be suitable for treatment with pembrolizumab (Keytruda).
A large study conducted in the 30 years has found that making simple lifestyle changes like eating healthy, working out, and losing a few pounds could halve the risk of developing type 2 diabetes. The study found that losing at least 6 pounds reduced the risk of diabetes by 40 to 47% in people who had prediabetes.
Al Roker has recently given an update about his health, revealing that he is now back home after undergoing prostate cancer surgery. He was diagnosed with prostate cancer on September 29 after getting an MRI and a biopsy. Roker posted a pic with his wife on Instagram to share he is doing well.
There is no clear evidence to suggest that diabetes drugs cause cancer. In fact, studies have found no such association. Given the fact that uncontrolled diabetes could increase the risk of cancer, patients should continue taking their medications as advised. Recently, a diabetes drug metformin has been recalled for containing a carcinogen.
Al Roker has recently thanks fans for their support after revealing his prostate cancer diagnosis. The 66-year-old journalist posted a video on Instagram and revealed that he will be undergoing prostate cancer surgery next week. He was diagnosed with prostate cancer on Sept. 29.
Smart drugs like modafinil and armodafinil are not designed for the treatment of cancer, but they might be recommended to treat cancer-related fatigue. Most patients with cancer often experience physical and mental fatigue, and smart drugs, aka nootropics, might help treat severe fatigue.